Objective: To assess and compare the benefits for patients with high-frequency hearing loss obtained from an implantable middle ear implant, the Symphonix Vibrant Soundbridge using the SIGNIA processing circuitry, to those derived from conventional amplification using the same integrated circuitry and to those derived from a variety of preoperatively worn hearing aids.
Study Design: A single-subject, repeated-measures study design was used for a comparative evaluation of the benefits derived from the Symphonix Vibrant Soundbridge and conventional amplification. Objective audiometric measures were performed postoperatively to compare the Symphonix Vibrant Soundbridge (404) and SIGNIA hearing aid, both using the SIGNIA processing chip.